MedPath

Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR

Not Applicable
Terminated
Conditions
SARS-CoV-2
Diagnosis
Covid-19
Polymerase Chain Reaction
Registration Number
NCT04361448
Lead Sponsor
Jessa Hospital
Brief Summary

The performance of 3 different sampling methods (2 nasopharyngeal swabs, 1 oropharyngeal swab) for the detection of SARS-CoV-2 with real-time reverse transcriptase polymerase chain reaction will be compared.

Detailed Description

Thirty volunteers will be recruited from health care workers suspicious for Covid-19, who consult the ocupational physician for Covid-19 testing.

For each volunteer, 3 swabs will be taken:

* Flocked eSwab (Copan, Italy) of the oropharynx

* Flocked nasopharyngeal eSwab (Copan, Italy) of the nasopharynx

* Dry flocked nasopharyngeal Swab, placed in lysis buffer Each swab will be tested for the presence of SARS-CoV-2 with an in-house reverse-transcriptase real-time PCR (Egene).

Performance of each method will be calculated.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • health care workers with symptoms suspicious for Covid-19
Exclusion Criteria
  • none

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
sensitivity1 month

sensitivity of each sampling method for the detection of SARS-CoV-2 by RT-PCR

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Jessa Hospital

🇧🇪

Hasselt, Belgium

Jessa Hospital
🇧🇪Hasselt, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.